Aura Biosciences Statistics

Total Valuation

AURA has a market cap or net worth of $364.85 million. The enterprise value is $144.37 million.

Market Cap	364.85M
Enterprise Value	144.37M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

AURA has 49.50 million shares outstanding. The number of shares has increased by 32.34% in one year.

Shares Outstanding	49.50M
Shares Change (YoY)	+32.34%
Shares Change (QoQ)	+16.93%
Owned by Insiders (%)	7.69%
Owned by Institutions (%)	83.25%
Float	30.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.55
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.76, with a Debt / Equity ratio of 0.09.

Current Ratio	18.76
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -42.20% and return on invested capital (ROIC) is -34.63%.

Return on Equity (ROE)	-42.20%
Return on Assets (ROA)	-36.70%
Return on Capital (ROIC)	-34.63%
Revenue Per Employee	n/a
Profits Per Employee	-$868,273
Employee Count	88
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AURA has paid $137,000 in taxes.

Income Tax	137,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.43% in the last 52 weeks. The beta is 0.35, so AURA's price volatility has been lower than the market average.

Beta (1Y)	0.35
52-Week Price Change	-20.43%
50-Day Moving Average	8.06
200-Day Moving Average	8.99
Relative Strength Index (RSI)	39.81
Average Volume (30 Days)	185,303

Short Selling Information

The latest short interest is 2.45 million, so 4.94% of the outstanding shares have been sold short.

Short Interest	2.45M
Short Previous Month	2.24M
Short % of Shares Out	4.94%
Short % of Float	7.90%
Short Ratio (days to cover)	8.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-84.99M
Pretax Income	-76.27M
Net Income	-76.41M
EBITDA	-73.14M
EBIT	-76.27M
Earnings Per Share (EPS)	-$1.93

Full Income Statement

Balance Sheet

The company has $226.17 million in cash and $19.56 million in debt, giving a net cash position of $206.61 million or $4.17 per share.

Cash & Cash Equivalents	226.17M
Total Debt	19.56M
Net Cash	206.61M
Net Cash Per Share	$4.17
Equity / Book Value	225.85M
Book Value Per Share	4.56
Working Capital	219.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.85 million and capital expenditures -$709,000, giving a free cash flow of -$64.56 million.

Operating Cash Flow	-63.85M
Capital Expenditures	-709,000
Free Cash Flow	-64.56M
FCF Per Share	-$1.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.34%
Shareholder Yield	-32.34%
Earnings Yield	-21.77%
FCF Yield	-18.39%

Analyst Forecast

The average price target for AURA is $21.00, which is 185.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	185.91%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2